This was the stock's third consecutive day of losses.
Beckman Coulter Diagnostics announced that the new DxC 500i Clinical Analyzer, an integrated clinical chemistry and immunoassay analyzer, ...
DXC Technology Co. closed 28.51% below its 52-week high of $24.83, which the company achieved on November 8th.
Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the new DxC 500i Clinical Analyzer, an ...
DXC Technology (DXC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. Key Insights DXC Technology's estimated fair value is US$28.05 ...
BREA, Calif., March 10, 2025 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the new DxC 500i Clinical Analyzer, an integrated clinical chemistry ...
Even though the number of people working in business and shared service centres in Slovakia declined slightly last year, the ...
DXC Technology (NYSE: DXC), a leading Fortune 500 global technology services provider, today announced new offerings with ServiceNow (NYSE: NOW), the AI platform for business transformation, to ...
In a report released yesterday, Daniel Perlin from RBC Capital maintained a Hold rating on Rocket Companies (RKT – Research Report), with a ...